IN the months of May and June, India will need to administer at least 125 million doses of COVID-19 vaccines as second doses alone. The upper limit of manufacturing capacity in the country is about 75 million doses per month. By most accounts, the actual production is less than this. For the month of May, so far only 41 million doses—or a little more than half—have been procured, or are available for procurement. It is clear , therefore, that India faces a severe shortage of vaccines even to cover second doses, and this shortage is likely to continue for the next few months.